News

Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed ...
Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...
Crohn’s disease (CD) is a chronic, progressive inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract—from the mouth to the anus. It most commonly affects the ...
A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...
A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...
Patients with Crohn's disease and long-term ileostomy experience endoscopic recurrence, with ileal involvement and prior ...
University of Birmingham medical student Nikhil Mistry gained a prestigious top prize at the 2025 Dr Falk Pharma/Guts UK ...
In this video, Joseph M. Runde, DO, attending physician in gastroenterology, hepatology and nutrition at Ann & Robert H. Lurie Children’s Hospital of Chicago and assistant professor of pediatrics at ...
Community for Crohn’s and Colitis Car Show returned to Port Crane today, raising money for those battling Crohn's and Colitis ...
Jim Loboy interviewed Robert Lucarell, who developed Crohn’s disease in 2018; the complications were almost fatal. This ...